Response Adapted Therapy With Bortezomib/Dexamethasone Followed by Addition of Lenalidomide in Non Responders as Initial Treatment for Patients With Multiple Myeloma
Clinical trial NCT01919086 · COMPLETED
Trial details
- NCT number
- NCT01919086
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-06
- Primary completion
- 2024-05-16
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.